The Plant-Type Ferredoxin-NADP+ Reductase/Ferredoxin Redox System as a Possible Drug Target Against Apicomplexan Human Parasites

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|24|3159-3172

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.24, 2005-09, pp. : 3159-3172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatty Acid Biosynthesis as a Drug Target in Apicomplexan Parasites

By  

Current Drug Targets, Vol. 8, Iss. 1, 2007-01 ,pp. : 15-30

Bentham Science Publishers

Access to resources Recommend Favorite

The Plastid-Like Organelle of Apicomplexan Parasites as Drug Target

By  

Current Pharmaceutical Design, Vol. 14, Iss. 9, 2008-01 ,pp. : 855-871

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Drug Targets in Apicomplexan Parasites

By  

Current Drug Targets, Vol. 8, Iss. 1, 2007-01 ,pp. : 49-60

Bentham Science Publishers

Access to resources Recommend Favorite

Isoprenoid Precursor Biosynthesis Offers Potential Targets for Drug Discovery Against Diseases Caused by Apicomplexan Parasites

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 16, 2011-08 ,pp. : 2048-2059

Bentham Science Publishers

Access to resources Recommend Favorite

Bisphosphonates as Chemotherapeutic Agents Against Trypanosomatid and Apicomplexan Parasites.

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 1, 2001-05 ,pp. : 51-61

Bentham Science Publishers

Access to resources Recommend Favorite